Clinical Trials Browser

Solid Tumor, Adult × Bevacizumab × 90 days × Clear all

NCT06265688 2026-02-20

First In Human Study of CX-2051 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult